Physician profile
Eman Ali
NPI 1467065458
$2,219.48
in general payments reported to CMS, 2019-2025
18 companies · $355 in 2025
The $355 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.08 · 2022: $835 · 2023: $847 · 2024: $120 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,322.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $488.55 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $442.64 | 2022-2025 | Jardiance, Mounjaro, Emgality |
| Astrazeneca Pharmaceuticals Lp | $330.77 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $316.71 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.66 | 2022-2023 | |
| Novo Nordisk INC | $97.91 | 2021-2025 | Ozempic |
| Sanofi-Aventis U.S. LLC | $71.99 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $65.62 | 2022-2023 | |
| Amarin Pharma, INC. | $55.58 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $54.24 | 2022 | |
| Exact Sciences Corporation | $34.41 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $31.05 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $23.65 | 2025 | Rexulti |
| Hologic Sales and Service, LLC | $21.25 | 2025 | Thinprep 2000 Processor, Aptima |
| Lundbeck LLC | $20.03 | 2025 | Rexulti |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $15.77 | 2023 | Vivitrol |
| Abbott Laboratories | $14.27 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eman Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.